for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Epigenomics receives FDA notification on pending approval decision for Epi proColon

Jan 8 (Reuters) - Epigenomics AG :

* Receives FDA notification about status of pending approval decision for Epi proColon

* FDA has informed company that already submitted and available data for Epigenomics’ blood-based CRC screening test Epi proColon would allow agency to come to a final determination on its safety and effectiveness Source text for Eikon: Further company coverage: (Gdynia Newsroom)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up